文献速递肿瘤 PET/CT

误差缓解使量子计算机上的PET影像组学癌症特征分析成为可能

Error mitigation enables PET radiomic cancer characterization on quantum computers.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2023-08-04

本研究利用已发表的11C-MET PET胶质瘤、68Ga-PSMA-11 PET前列腺癌和18F-FDG PET肺癌影像组学数据集,在模拟器和21量子比特IonQ Aria量子计算机上比较经典机器学习与量子机器学习预测临床终点的性能。结果显示经误差缓解后,量子设备测试平衡准确率从69.94%提升至75.66%。

要点

  • 在16特征数据集中,模拟器环境量子机器学习平均平衡准确率70%,经典机器学习为69%。
  • 在8特征数据集中,经典机器学习较量子机器学习平均平衡准确率高1%。
  • IonQ设备上经误差缓解后测试平衡准确率由69.94%升至75.66%。

核心结论

  • 在临床相关PET癌症队列中预测临床终点时,经误差缓解后可在现有真实量子计算机上实现量子优势。
  • 在模拟器环境中依靠量子机器学习即可在这些队列中实现量子优势。

研究设计与样本

  • 研究使用已发表的PET影像组学数据集,包括11C-MET PET胶质瘤、68Ga-PSMA-11 PET前列腺癌和18F-FDG PET肺癌,临床终点分别为3年生存、低危与高危Gleason风险及2年生存。
  • 采用0.7、0.8和0.9的Spearman秩阈值进行冗余缩减,并从所有队列中选择8个和16个特征,形成18个数据集变体。
  • 在模拟器环境中训练和测试5种经典机器学习及其量子版本,随后在21量子比特IonQ Aria量子计算机上训练和测试选定的量子机器学习方法。
  • 预测性能以测试平衡准确率评估,量子优势以几何差异评分估计。

主要发现

  • 在16特征数据集中,量子机器学习平均平衡准确率为70%,经典机器学习为69%。
  • 在8特征数据集中,经典机器学习较量子机器学习平均平衡准确率高1%。
  • 量子机器学习最高平均优势为+4%。
  • 在8特征的所有案例中几何差异评分≤1.0,而在11个案例中量子机器学习优于经典机器学习的有9个其几何差异评分>1.0。
  • IonQ设备上选定量子机器学习方法和数据集的测试平衡准确率为69.94%,误差缓解后测试平衡准确率提升至75.66%,无噪声模拟器中为76.77%。

关键数值与推荐

  • 冗余缩减采用0.7、0.8和0.9的Spearman秩阈值。
  • 特征选择采用8个和16个特征,形成18个数据集变体。
  • 量子优势以几何差异评分估计,8特征案例中≤1.0,量子机器学习优于经典机器学习的11个案例中9个>1.0。
  • 预测性能以测试平衡准确率评估。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cancer is a leading cause of death worldwide. While routine diagnosis of cancer is performed mainly with biopsy sampling, it is suboptimal to accurately characterize tumor heterogeneity. Positron emission tomography (PET)-driven radiomic research has demonstrated promising results when predicting clinical endpoints. This study aimed to investigate the added value of quantum machine learning both in simulator and in real quantum computers utilizing error mitigation techniques to predict clinical endpoints in various PET cancer patients. METHODS: Previously published PET radiomics datasets including 11C-MET PET glioma, 68GA-PSMA-11 PET prostate and lung 18F-FDG PET with 3-year survival, low-vs-high Gleason risk and 2-year survival as clinical endpoints respectively were utilized in this study. Redundancy reduction with 0.7, 0.8, and 0.9 Spearman rank thresholds (SRT), followed by selecting 8 and 16 features from all cohorts, was performed, resulting in 18 dataset variants. Quantum advantage was estimated by Geometric Difference (GDQ) score in each dataset variant. Five classic machine learning (CML) and their quantum versions (QML) were trained and tested in simulator environments across the dataset variants. Quantum circuit optimization and error mitigation were performed, followed by training and testing selected QML methods on the 21-qubit IonQ Aria quantum computer. Predictive performances were estimated by test balanced accuracy (BACC) values. RESULTS: On average, QML outperformed CML in simulator environments with 16-features (BACC 70% and 69%, respectively), while with 8-features, CML outperformed QML with + 1%. The highest average QML advantage was + 4%. The GDQ scores were ≤ 1.0 in all the 8-feature cases, while they were > 1.0 when QML outperformed CML in 9 out of 11 cases. The test BACC of selected QML methods and datasets in the IonQ device without error mitigation (EM) were 69.94% BACC, while EM increased test BACC to 75.66% (76.77% in noiseless simulators). CONCLUSIONS: We demonstrated that with error mitigation, quantum advantage can be achieved in real existing quantum computers when predicting clinical endpoints in clinically relevant PET cancer cohorts. Quantum advantage can already be achieved in simulator environments in these cohorts when relying on QML.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Moradi S, Spielvogel C, Krajnc D, et al. Error mitigation enables PET radiomic cancer characterization on quantum computers. Eur J Nucl Med Mol Imaging. 2023. PMID: 37540237. doi:10.1007/s00259-023-06362-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。